Ondine Biomedical Inc (AIM:OBI) will perform a poster presentation at next week's IP2023 conference sharing the results of an in vitro study evaluating the efficacy of its photodisinfection technology on multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria.
Taking place in Liverpool from 17-19 October, the conference is organized by the Infection Prevention Society and is the largest annual infection prevention conference in the UK and Ireland.
The poster presentation, 'Antimicrobial Photodynamic Therapy Against Extensively Drug-Resistant (XDR) Gram Negative Isolates With Novel Antibiotic Resistance Factors', will be presented at IP2023 between 1:10pm and 2:40pm on Wednesday 18 October.
Ondine said it will release a further announcement providing more details of the research around the same time as the presentation starts.